Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Timothy Miller

Washington University, Department: Neurology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Biogen IDEC

Disclosed Value
Listed Reason
Payment for services (e.g., consulting fees, honoraria, paid authorship)

Based on WU’s Research COI Policy and the Procedures for Determining and Managing Research Financial Conflicts of Interests, Washington University determined Dr. Miller's personal financial relationship with Biogen Idec, related to the above referenced research creates a financial conflict of interest due to the following reasons:

•Dr. Miller's personal financial relationship is directly related to the study because the primary goal of the research, the development of an antisense oligonucleotide inhibitor, is the same focus of the consulting he provides to the company’s advisory board

•Dr. Miller's role as PI of the research will directly affect all aspects of the study.

Listed Research Project
Development of an antisense oligonucleotide therapy for SOD1 Familial ALS

There are no adequate therapies for SOD1-related ALS or sporadic ALS and thus these efforts may define a new therapy for a devastating untreatable disorder. In addition, the research strategy being pioneered here is likely to apply to C9orf72-related ALS as well as many other neurodegenerative syndromes for which an mRNA target has been identified.

Filed on May 16, 2015.

Tell us what you know about Timothy Miller's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page